Home / Indicator library / Biotechnology and Medical Care / Bioptik (4161) overview
Bioptik (4161) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Bioptik, on one pageBioptik (4161) snapshot, key figures
Bioptik (4161): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→4161: common questions
What is 4161's P/E ratio?
4161 traded at a price-to-earnings ratio of 17.94x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 4161's dividend yield?
4161's cash dividend yield was 3.15% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 4161's revenue growing?
4161 reported -1.3% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 4161's price / earnings high or low right now?
4161's price / earnings is 17.94x, which is below its one-year median of 20.61x and sits at the 3rd percentile of the 16.61–25.28x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 4161's dividend yield high or low right now?
4161's dividend yield is 3.15%, which is below its one-year median of 5.56% and sits at the 41st percentile of the 2.74–6.47% range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.